1) Feldman HA, Goldstein I, Hatzichristou DG, et al : Impotence and its medical and psychosocial correlates : results of the Massachusetts male Aging Study. J Urol 151 : 54─61, 1994
2) Yamasaki H, Ogawa K, Sasaki H, et al : Prevalence and risk factors of erectile dysfunction in Japanese men with type 2 diabetes. Diabetes Res Clin Pract 66S : S173─177, 2004
3) Sasaki H, Yamasaki H, Ogawa K, et al : Prevalence and risk factors for erectile dysfunction in Japanese diabetics. Diabetes Res Clin Pract 70 : 81─89, 2005
4) Fukui M, Tanaka M, Okada H, et al : Five-item version of the international index of erectile function correlated with albuminuria and subclinical atherosclerosis in men with type 2 diabetes. J Atheroscler Thromb 18 : 991─997, 2011
5) Furukawa S, Sakai T, Niiya T, et al : Nocturia and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus : The Dogo Study. J Diabetes Investig 7 : 786─790, 2016
6) Fedele D, Bortolotti A, Coscelli C, et al : Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol 29 : 524─531, 2000
7) Gazzaruso C, Giordanetti S, De Amici E, et al : Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110 : 22─26, 2004
8) Furukawa S, Sakai T, Niiya T, et al : Alcohol consumption and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus : baseline data from The Dogo Study. Alcohol 55 : 17─22, 2016
9) Perimenis P, Konstantinopoulos A, Karkoulias K, et al : Sildenafil combined with continuous positive airway pressure for treatment of erectile dysfunction in men with obstructive sleep apnea. Int Urol Nephrol 39 : 547─552, 2007
10) Vickers MA and Satyanarayana R : Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 14 : 466─471, 2002
11) Gupra BP, Muras Mh, Clifton MM, et al : The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction : a systematic review and meta-analysis. Arch Intern Med 171 : 1797─1803, 2011
12) Grover-Páez F, Villegas Rivera G and Guillén Ortíz R : Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes. Diabetes Res Clin Pract 78 : 136─140, 2007
13) Hill KD, Eckhauser AW, Marney A, et al : Phosphodiesterase 5 inhibition improves beta-cell function in metabolic syndrome. Diabetes Care 32 : 857─859, 2009